Naess O, Haug E, Attramadal A, Gautvik K M
Acta Endocrinol (Copenh). 1982 May;100(1):25-30. doi: 10.1530/acta.0.1000025.
Progesterone and corticosterone have a similar effect on the production of growth hormone (GH) and prolactin (Prl) by pituitary tumour cells (GH3 cells) in culture. Previously we have shown that progesterone has a high affinity for the glucocorticoid receptors in these cells. Progesterone may therefore exert its effects through binding to the glucocorticoid receptor. The aim of the present study was to investigate if the GH3 tumour cells and an oestrogen induced pituitary tumours, which also produce GH and Prl, possess specific receptors for progesterone. Both the GH3 tumours and the oestrogen induced pituitary tumour were in fact found to possess cytoplasmatic receptor molecules for progesterone by using the potent progestin R5020 as a marker. Isoelectric focusing revealed one binding component (pH 5.9), which was of protein nature. The binding was of high affinity (KD 2 X 10(-9) mol/l). In the oestrogen induced tumour, the maximal binding was 70 fmol/mg cytosol protein. In female rats with GH3 tumours the binding was 55 fmol/mg cytosol protein. Priming of the animals with 1 mg oestradiol-valerate increased the binding to 116 fmol/mg cytosol protein, whereas very little binding was found in GH3 tumours from rats castrated 7 days before sacrifice. The receptors in the oestrogen induced pituitary tumour and the GH3 tumours exhibited high affinity for R5020 and progesterone, whereas corticosterone had no significant affinity for the receptors. Using exchange assay, it was demonstrated that the cytoplasmic progestin receptors could be translocated to the nucleus after administration of progesterone to the animals. Thus, the presence of specific progesterone receptors, different from the glucocorticoid receptors, strongly indicates that athe effects of progesterone on GH and Prl production are mediated through the progesterone receptors.
孕酮和皮质酮对培养的垂体肿瘤细胞(GH3细胞)生长激素(GH)和催乳素(Prl)的产生具有相似作用。此前我们已表明,孕酮对这些细胞中的糖皮质激素受体具有高亲和力。因此,孕酮可能通过与糖皮质激素受体结合发挥其作用。本研究的目的是调查GH3肿瘤细胞以及雌激素诱导的垂体肿瘤(也产生GH和Prl)是否具有孕酮特异性受体。事实上,通过使用强效孕激素R5020作为标志物,发现GH3肿瘤和雌激素诱导的垂体肿瘤均具有孕酮细胞质受体分子。等电聚焦显示一个结合成分(pH 5.9),其具有蛋白质性质。结合具有高亲和力(KD 2×10⁻⁹mol/L)。在雌激素诱导的肿瘤中,最大结合量为70 fmol/mg细胞质蛋白。在患有GH3肿瘤的雌性大鼠中,结合量为55 fmol/mg细胞质蛋白。用1 mg戊酸雌二醇对动物进行预处理可使结合量增加至116 fmol/mg细胞质蛋白,而在处死前7天阉割的大鼠的GH3肿瘤中几乎未发现结合。雌激素诱导的垂体肿瘤和GH3肿瘤中的受体对R5020和孕酮表现出高亲和力,而皮质酮对受体无明显亲和力。使用交换试验表明,给动物注射孕酮后,细胞质孕激素受体可转位至细胞核。因此,特异性孕酮受体的存在(不同于糖皮质激素受体)强烈表明,孕酮对GH和Prl产生的作用是通过孕酮受体介导的。